MedPath

海南卫康制药(潜山)有限公司

Ownership
-
Established
2002-07-10
Employees
-
Market Cap
-
Website
www.weikang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Lornoxicam for Injection

Product Name
注射用氯诺昔康
Approval Number
国药准字H20254238
Approval Date
May 20, 2025
NMPA

Roxatidine Acetate Hydrochloride for Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20254022
Approval Date
Apr 30, 2025
NMPA

Ceftezole Sodium

Product Name
头孢替唑钠
Approval Number
国药准字H20083112
Approval Date
Nov 12, 2024
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20244143
Approval Date
Jun 25, 2024
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20244144
Approval Date
Jun 25, 2024
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20143050
Approval Date
Sep 28, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20143049
Approval Date
Sep 28, 2023
NMPA

Lansoprazole for Injection

Product Name
注射用兰索拉唑
Approval Number
国药准字H20193058
Approval Date
Sep 27, 2023
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20084325
Approval Date
Aug 14, 2023
NMPA

Ceftezole Sodium for Injection

Product Name
注射用头孢替唑钠
Approval Number
国药准字H20084328
Approval Date
Aug 14, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.